THE CENTER FOR SPINAL SURGERY — History
CCN 440218 | 3-year financial timeline | COVID resilience: 54/100
🛡️ Public data only — no PHI permitted on this instance.
$79M
Latest Revenue (FY2022)
+7.4%
Revenue CAGR (3yr)
39.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $68M | $75M | $79M | +5.4% | +7.4% |
| Operating Expenses | $39M | $44M | $48M | +9.4% | +10.9% |
| Operating Margin | 43.0% | 41.6% | 39.3% | -5.3% | -4.4% |
| Net Income | $29M | $31M | $31M | -0.2% | +2.7% |
| Licensed Beds | 23 | 23 | 23 | +0.0% | +0.0% |
| Total Patient Days | 2,572 | 2,280 | 2,493 | +9.3% | -1.5% |
| Medicare Day % | 24% | 37% | 29% | -21.1% | +9.9% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 54/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +15.4% ($68M → $79M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+7.4%
This Hospital
+7.6%
State Avg
Latest Margin
39.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $84M | 37.5% |
| FY2024 (proj) | $89M | 35.6% |
| FY2025 (proj) | $94M | 33.8% |